Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsRent ExpenseShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Acadia Healthcare Company (ACHC) Short-Term Debt issuances (2016 - 2025)

Historic Short-Term Debt issuances for Acadia Healthcare Company (ACHC) over the last 8 years, with Q3 2025 value amounting to $45.0 million.

  • Acadia Healthcare Company's Short-Term Debt issuances fell 1000.0% to $45.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $970.0 million, marking a year-over-year increase of 36190.48%. This contributed to the annual value of $305.0 million for FY2024, which is 66250.0% up from last year.
  • Latest data reveals that Acadia Healthcare Company reported Short-Term Debt issuances of $45.0 million as of Q3 2025, which was down 1000.0% from $70.0 million recorded in Q2 2025.
  • Over the past 5 years, Acadia Healthcare Company's Short-Term Debt issuances peaked at $760.0 million during Q1 2025, and registered a low of $40.0 million during Q1 2023.
  • Over the past 4 years, Acadia Healthcare Company's median Short-Term Debt issuances value was $70.0 million (recorded in 2021), while the average stood at $191.1 million.
  • Examining YoY changes over the last 5 years, Acadia Healthcare Company's Short-Term Debt issuances showed a top increase of 37500.0% in 2025 and a maximum decrease of 1000.0% in 2025.
  • Quarter analysis of 4 years shows Acadia Healthcare Company's Short-Term Debt issuances stood at $70.0 million in 2021, then plummeted by 42.86% to $40.0 million in 2023, then soared by 137.5% to $95.0 million in 2024, then crashed by 52.63% to $45.0 million in 2025.
  • Its Short-Term Debt issuances was $45.0 million in Q3 2025, compared to $70.0 million in Q2 2025 and $760.0 million in Q1 2025.